AIRLINK 176.82 Decreased By ▼ -0.07 (-0.04%)
BOP 11.09 Decreased By ▼ -0.26 (-2.29%)
CNERGY 7.94 No Change ▼ 0.00 (0%)
FCCL 44.94 Decreased By ▼ -0.47 (-1.04%)
FFL 16.11 Decreased By ▼ -0.21 (-1.29%)
FLYNG 28.28 Increased By ▲ 0.43 (1.54%)
HUBC 141.78 Increased By ▲ 2.80 (2.01%)
HUMNL 13.25 Increased By ▲ 0.05 (0.38%)
KEL 4.43 Increased By ▲ 0.02 (0.45%)
KOSM 6.03 Decreased By ▼ -0.11 (-1.79%)
MLCF 58.45 Decreased By ▼ -0.41 (-0.7%)
OGDC 224.19 Increased By ▲ 6.02 (2.76%)
PACE 5.93 Decreased By ▼ -0.04 (-0.67%)
PAEL 45.90 Increased By ▲ 0.03 (0.07%)
PIAHCLA 18.16 Decreased By ▼ -0.07 (-0.38%)
PIBTL 10.60 Increased By ▲ 0.05 (0.47%)
POWER 11.30 Decreased By ▼ -0.21 (-1.82%)
PPL 185.48 Increased By ▲ 0.98 (0.53%)
PRL 36.91 Decreased By ▼ -0.13 (-0.35%)
PTC 23.69 Decreased By ▼ -0.39 (-1.62%)
SEARL 98.40 Increased By ▲ 0.74 (0.76%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 37.38 Increased By ▲ 0.06 (0.16%)
SYM 15.01 Decreased By ▼ -0.33 (-2.15%)
TELE 7.82 Decreased By ▼ -0.05 (-0.64%)
TPLP 10.96 Decreased By ▼ -0.15 (-1.35%)
TRG 66.14 Decreased By ▼ -4.06 (-5.78%)
WAVESAPP 10.88 Decreased By ▼ -0.22 (-1.98%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
YOUW 3.81 Decreased By ▼ -0.01 (-0.26%)
AIRLINK 176.82 Decreased By ▼ -0.07 (-0.04%)
BOP 11.09 Decreased By ▼ -0.26 (-2.29%)
CNERGY 7.94 No Change ▼ 0.00 (0%)
FCCL 44.94 Decreased By ▼ -0.47 (-1.04%)
FFL 16.11 Decreased By ▼ -0.21 (-1.29%)
FLYNG 28.28 Increased By ▲ 0.43 (1.54%)
HUBC 141.78 Increased By ▲ 2.80 (2.01%)
HUMNL 13.25 Increased By ▲ 0.05 (0.38%)
KEL 4.43 Increased By ▲ 0.02 (0.45%)
KOSM 6.03 Decreased By ▼ -0.11 (-1.79%)
MLCF 58.45 Decreased By ▼ -0.41 (-0.7%)
OGDC 224.19 Increased By ▲ 6.02 (2.76%)
PACE 5.93 Decreased By ▼ -0.04 (-0.67%)
PAEL 45.90 Increased By ▲ 0.03 (0.07%)
PIAHCLA 18.16 Decreased By ▼ -0.07 (-0.38%)
PIBTL 10.60 Increased By ▲ 0.05 (0.47%)
POWER 11.30 Decreased By ▼ -0.21 (-1.82%)
PPL 185.48 Increased By ▲ 0.98 (0.53%)
PRL 36.91 Decreased By ▼ -0.13 (-0.35%)
PTC 23.69 Decreased By ▼ -0.39 (-1.62%)
SEARL 98.40 Increased By ▲ 0.74 (0.76%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 37.38 Increased By ▲ 0.06 (0.16%)
SYM 15.01 Decreased By ▼ -0.33 (-2.15%)
TELE 7.82 Decreased By ▼ -0.05 (-0.64%)
TPLP 10.96 Decreased By ▼ -0.15 (-1.35%)
TRG 66.14 Decreased By ▼ -4.06 (-5.78%)
WAVESAPP 10.88 Decreased By ▼ -0.22 (-1.98%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
YOUW 3.81 Decreased By ▼ -0.01 (-0.26%)
BR100 12,435 Increased By 81.3 (0.66%)
BR30 38,584 Increased By 460.3 (1.21%)
KSE100 116,633 Increased By 193.6 (0.17%)
KSE30 35,822 Increased By 118.6 (0.33%)

The US is fast-tracking antimalarial drugs for use as a treatment against the new coronavirus, President Donald Trump said Thursday.
The announcement follows encouraging research into chloroquine and hydroxychloroquine in France and China, but many in the wider scientific community have cautioned more work is needed to prove they really work for COVID-19.
"We're going to be able to make that drug available almost immediately, and that's where the (Food and Drug Administration) has been so great," Trump told reporters, referring to both antimalarials.
"They've gone through the approval process - it's been approved. They took it down from many, many months to immediate. So we're going to be able to make that drug available by prescription."
The US has recorded 10,755 cases of new coronavirus infection, 154 of them fatal. But authorities expect the number to increase steeply in the coming days because of increased levels of testing after initial delays.
FDA Commissioner Stephen Hahn said that, while the antimalarials have not yet been formally approved, access was being expanded so that authorities could gather more data.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.